MedPath

UNDA 19

UNDA 19

Discontinued
DIN Number

02233234

Drug Class

Human

Market Date

Apr 6, 1998

Company
HC

seroyal international inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02233234
AIG Number0528099001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid ,  Tablet ,  Granules ,  Drops ,  Pellet
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (5)

ALUMINUMActive
Strength: 12 X
Monograph: ALUMINUM
DROSERA ROTUNDIFOLIAActive
Strength: 5 X
Monograph: DROSERA ROTUNDIFOLIA
PEPPERMINTActive
Strength: 5 X
Monograph: PEPPERMINT
SENEGAActive
Strength: 4 X
Monograph: SENEGA
STAR ANISEActive
Strength: 3 X
Monograph: STAR ANISE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.